1. Dr. Ewen Chee appointed Lead Doctor for Asia Strategy at SBC. 2. SBC aims to recruit and train physicians in Asia-Pacific. 3. Singapore recognized as a hub for aesthetic medicine. 4. AHH's brand will support SBC's global strategy. 5. Focus on sustainable growth in the aesthetic medicine sector.
The appointment of Dr. Chee strengthens SBC's leadership in medical aesthetics, indicating growth potential. Historically, similar strategic appointments in companies have led to bullish market reactions.
This development is critical for SBC's expansion strategy and signals a commitment to leadership in the growing aesthetic market.
SBC's initiatives in physician training and recruitment will likely yield benefits over multiple years. Strategic health market expansions typically require time before impacts on revenue are seen.
SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that Dr. Ewen Chee, founder of Singapore's leading aesthetic medical company Aesthetic Healthcare Holdings ("AHH"), has been appointed President of AHH and Lead Doctor for Asia Strategy at SBC Medical Group. In this role, Dr. Chee will support physician recruitment and training across the Asia-Pacific region, contributing to SBC's global strategy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250825055997/en/
SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion
Singapore is internationally recognized as a trusted destination for aesthetic medicine, supported by its robust medical infrastructure and stringent regulatory environment. Leveraging its geographic advantages, the country attracts patients from neighboring Indonesia, Malaysia, Thailand, and Vietnam, and has developed into a center of medical tourism, establishing itself as the "Aesthetic Medicine Hub of Asia."
In this environment, Dr. Chee has accumulated more than 20 years of clinical experience and is regarded as a pioneer of aesthetic medicine in Singapore. In 1999, he founded The Chelsea Clinic, among the first to introduce IPL treatments domestically. He has served as an international trainer in various types of fillers, lasers, botulinum toxin, and thread lifts. In addition, he acted as Co-Chair of the Asia-Pacific Thread Lift Meeting (APEM), earning broad international recognition through education and speaking activities. Dr. Chee is also a certified physician of the American Academy of Aesthetic Medicine (AAAM), with his expertise presented at numerous international congresses and workshops.
Looking ahead, SBC will leverage Dr. Chee's expertise and AHH's brand portfolio to establish a scalable platform for physician recruitment and training across Asia-Pacific. Anchored by its group purpose, "Contributing to the happiness of people worldwide through medical innovation," the Group is building a foundation for sustainable growth and expanding its leadership position in the global aesthetic medicine industry.
About Aesthetic Healthcare Holdings Pte. Ltd.
AHH is based in Singapore and operates aesthetic medical clinics, family clinics, and quick facial aesthetics outlets. The founder, Dr. Ewen Chee, is known as one of the pioneers in the field of aesthetic medicine in Singapore and is a co-chair of the first Asia Pacific Thread Lift Conference (APEM) and a board-certified physician by the American Academy of Aesthetic Medicine. He is a frequent speaker at international conferences and workshops, and his expertise and knowledge have been featured in numerous scientific publications.
AHH Major brands and number of clinics:
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensing of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.
For more information, visit https://sbc-holdings.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250825055997/en/
SBC Medical Group Holdings Incorporated (Asia)
Hikaru Fukui / Head of Investor Relations E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Head of Public Relations E-mail: pr@sbc.or.jp
ICR LLC (In the US)
Bill Zima / Managing Partner Email: bill.zima@icrinc.com